PAVmed Total Revenue from 2010 to 2025

PAVMZ Stock  USD 0  0  30.00%   
PAVmed Series Total Revenue yearly trend continues to be fairly stable with very little volatility. Total Revenue will likely drop to about 1.5 M in 2025. Total Revenue is the total amount of income generated by the sale of goods or services related to PAVmed Series' primary operations. View All Fundamentals
 
Total Revenue  
First Reported
2017-09-30
Previous Quarter
979 K
Current Value
996 K
Quarterly Volatility
5.1 M
 
Covid
Check PAVmed Series financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PAVmed Series' main balance sheet or income statement drivers, such as Interest Expense of 1.2 M, Selling General Administrative of 37.4 M or Other Operating Expenses of 86 M, as well as many indicators such as Price To Sales Ratio of 13.27, Dividend Yield of 3.0E-4 or Days Sales Outstanding of 14.05. PAVmed financial statements analysis is a perfect complement when working with PAVmed Series Valuation or Volatility modules.
  
Check out the analysis of PAVmed Series Correlation against competitors.

Latest PAVmed Series' Total Revenue Growth Pattern

Below is the plot of the Total Revenue of PAVmed Series Z over the last few years. Total revenue comprises all receipts PAVmed Series Z generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. PAVmed Series' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PAVmed Series' overall financial position and show how it may be relating to other accounts over time.
Total Revenue10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

PAVmed Total Revenue Regression Statistics

Arithmetic Mean5,441,195
Geometric Mean0.00
Coefficient Of Variation87.48
Mean Deviation4,558,805
Median10,000,000
Standard Deviation4,760,177
Sample Variance22.7T
Range10M
R-Value(0.82)
Mean Square Error8.1T
R-Squared0.67
Significance0.0001
Slope(815,584)
Total Sum of Squares339.9T

PAVmed Total Revenue History

20251.5 M
20242.2 M
20232.5 M
2022377 K
2021500 K
2018null

About PAVmed Series Financial Statements

PAVmed Series investors use historical fundamental indicators, such as PAVmed Series' Total Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in PAVmed Series. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue2.2 M1.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.